Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients

被引:3
|
作者
Feng, Jian [1 ,2 ]
Liang, Bin [2 ]
Zhang, Hang-Yu [2 ]
Liu, Zhe [2 ]
Jiang, Kai [2 ]
Zhao, Xiang-Qian [2 ,3 ]
机构
[1] Peking Univ, Dept Hepatopancreatobiliary Surg, Shougang Hosp, Beijing 100144, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Inst Hepatobiliary Surg Chinese PLA, Fac Hepatopancreato Biliary Surg, Key Lab Digital Hepatobiliary Surg, Beijing 100853, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Inst Hepatobiliary Surg Chinese PLA, Fac Hepatopancreato Biliary Surg, Key Lab Digital Hepatobiliary Surg, 28 Fuxing Rd, Beijing 100853, Peoples R China
来源
关键词
Intrahepatic cholangiocarcinoma; Mass-forming; Treatment; Prognosis; HEPATITIS-B-VIRUS; SURVIVAL RATE; SURGERY; OUTCOMES;
D O I
10.4240/wjgs.v14.i5.442
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer in humans after hepatocellular carcinoma and a rare epithelial malignancy that results in a poor prognosis. According to the Liver Cancer Study Group of Japan classification, ICC can be divided into three types: Mass-forming (MF) type, periductal-infiltrating (PI) type, and intraductal-growth type. The MF type is the most common, accounting for 57.1-83.6% of ICCs. Nevertheless, little is known about the epidemiology and treatment of MF ICC. AIM To examine the prognostic factors for patients with MF ICC. METHODS We carried out a retrospective analysis of consecutive patients with MF ICC treated at the Faculty of Hepato-Pancreato-Biliary Surgery of Chinese PLA General Hospital between January 2008 and December 2018. According to the treatment received, the patients were divided into either a resection group or an exploration group. RESULTS The pooled 1-, 3-, and 5-year survival rates in the 68 patients with MF ICC were 66.5%, 36.3%, and 9.3%, respectively. Univariate analysis revealed that surgical resection (P < 0.001), nodal metastasis (P < 0.001), tumor location (P = 0.039), vascular invasion (P < 0.001), ascites (P < 0.001), and differentiation (P = 0.009) were significantly associated with the prognosis and survival of MF ICC. Multivariate analysis revealed that ascites (hazard ratio [HR] = 5.6, 95% confidence interval [CI]: 1.6-18.9, P = 0.006) and vascular invasion (HR = 2.5, 95%CI: 1.0-6.1, P = 0.045) were independent risk factors for MF ICC. The pooled 1-, 3-, and 5-year survival rates in the 19 patients of the exploration group were 5.3%, 5.3%, and 0, respectively. Among the 49 patients who underwent surgical resection, the pooled 1-, 3-, and 5-year survival rates were 93.5%, 49.7%, and 14.4%, respectively. Univariate and multivariate analyses revealed that vascular invasion (HR = 3.1, 95%CI: 1.2-8.5, P = 0.024) and nodal metastasis (HR = 3.2, 95%CI: 1.4-7.6, P = 0.008) were independent prognostic risk factors for surgical resection patients. CONCLUSION The prognosis of MF ICC patients is dismal, especially those with ascites or vascular invasion. Surgical resection is a key factor in improving overall survival in patients with MF ICC, and vascular invasion and lymph node metastasis affect the efficacy of surgical resection.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 50 条
  • [41] Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma
    Sasaki, A
    Kawano, K
    Aramaki, M
    Ohno, T
    Tahara, K
    Kitano, S
    [J]. HEPATO-GASTROENTEROLOGY, 2004, 51 (55) : 224 - 228
  • [42] Combined arterial and delayed enhancement patterns of MRI assist in prognostic prediction for intrahepatic mass-forming cholangiocarcinoma (IMCC)
    Jin, Kai-pu
    Sheng, Rou-fan
    Yang, Chun
    Zeng, Meng-su
    [J]. ABDOMINAL RADIOLOGY, 2022, 47 (02) : 640 - 650
  • [43] Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma
    Inoue, K
    Makuuchi, M
    Takayama, T
    Torzilli, G
    Yamamoto, J
    Shimada, K
    Kosuge, T
    Yamasaki, S
    Konishi, M
    Kinoshita, T
    Miyagawa, S
    Kawasaki, S
    [J]. SURGERY, 2000, 127 (05) : 498 - 505
  • [44] Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma
    Agostino Maria De Rose
    Alessandro Cucchetti
    Gennaro Clemente
    Francesco Ardito
    Ivo Giovannini
    Giorgio Ercolani
    Felice Giuliante
    Antonio Daniele Pinna
    Gennaro Nuzzo
    [J]. Journal of Gastrointestinal Surgery, 2013, 17 : 739 - 747
  • [45] Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma
    De Rose, Agostino Maria
    Cucchetti, Alessandro
    Clemente, Gennaro
    Ardito, Francesco
    Giovannini, Ivo
    Ercolani, Giorgio
    Giuliante, Felice
    Pinna, Antonio Daniele
    Nuzzo, Gennaro
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2013, 17 (04) : 739 - 747
  • [46] Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers
    Li Zhao
    Xiaohong Ma
    Meng Liang
    Dengfeng Li
    Peiqing Ma
    Sicong Wang
    Zhiyuan Wu
    Xinming Zhao
    [J]. Cancer Imaging, 19
  • [47] Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers
    Zhao, Li
    Ma, Xiaohong
    Liang, Meng
    Li, Dengfeng
    Ma, Peiqing
    Wang, Sicong
    Wu, Zhiyuan
    Zhao, Xinming
    [J]. CANCER IMAGING, 2019, 19 (1):
  • [48] Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma
    Teraoku, Hiroki
    Morine, Yuji
    Uyama, Naoto
    Ikemoto, Tetsuya
    Iwahashi, Shuichi
    Saito, Yu
    Takasu, Chie
    Imura, Satoru
    Harada, Masafumi
    Shimada, Mitsuo
    [J]. WORLD JOURNAL OF SURGERY, 2020, 44 (07) : 2350 - 2358
  • [49] Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic Cholangiocarcinoma
    Hiroki Teraoku
    Yuji Morine
    Naoto Uyama
    Tetsuya Ikemoto
    Shuichi Iwahashi
    Yu Saito
    Chie Takasu
    Satoru Imura
    Masafumi Harada
    Mitsuo Shimada
    [J]. World Journal of Surgery, 2020, 44 : 2350 - 2358
  • [50] Surgical Treatment of Mass-Forming Intrahepatic Cholangiocarcinoma: An 11-Year Western Single-Center Experience in 107 Patients
    Yedibela, Sueleyman
    Demir, Resit
    Zhang, Wei
    Meyer, Thomas
    Hohenberger, Werner
    Schoenleben, Frank
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) : 404 - 412